Mulligan Mobilization With Movement Method in the Treatment of Shoulder Problems

Comparison of Conventional Therapy and Mulligan Mobilization With Movement Method in the Treatment of Shoulder Problems: A Randomized Clinical Trial

To determine whether Mulligan mobilization with movement (MWM) and Conservative treatment CT give different results on pain, ROM, and functional activities in participants with shoulder problems.

Study Overview

• Status: Completed
• Conditions: Pain; Shoulder Syndrome
• Intervention / Treatment: Other: CT+MWM; Other: CT

Detailed Description

Shoulder problems are one of the common orthopedic problems. Patients with shoulder problems experience an increase in pain and a decrease in joint movement and functionality. With conventional treatment, patients' symptoms improve. However, the MWM is one of the manual therapy techniques frequently used to reduce pain in musculoskeletal system problems. It is extremely important to evaluate patients' functionality after rehabilitation. Although there are studies comparing the effect of MWM in the literature, studies evaluating patient-specific functionality are also limited.

• Study Type: Interventional
• Enrollment (Actual): 41
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • Esenboğa
    • Ankara, Esenboğa, Turkey, 06970
      • Ankara Yıldırım Beyazıt University, Faculty of Health Sciences,Department of Physiotherapy and Rehabilitation

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Being over 18 years old,
• Having any shoulder problems (impingement, rotator cuff syndrome, glenohumeral joint problems, etc.),
• Having a history of shoulder pain lasting at least 3 months, and volunteering to participate in the study.

Exclusion Criteria:

• Having systemic or degenerative disease, a neurological disease, and
• Having more than one upper extremity pathology.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: MWM Group; This group received treatment with the Mulligan technique.	Other: CT+MWM; The MWM technique was applied to the MWM group in addition to the CT. The MWM technique was applied in flexion, abduction, internal rotation, and external rotation directions. The MWM technique was performed with 3 sets of 10 repetitions.
Active Comparator: CT Group; This group received treatment with the conventional therapy.	Other: CT; Cold packs, electrotherapy modalities, scapular mobilization, stretching, and strengthening exercises were applied to the CT group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Shoulder pain	The Numeric Pain Rating Scale was used to evaluate shoulder pain. The patient was asked to mark the point corresponding to the pain between 0 and 10. The higher the score, the higher the pain.	through study completion, an average of 6 month

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
ROM	Shoulder flexion, abduction, internal and external rotation were measured using a Universal goniometer.As the angle increases, the joint range of motion increases.	through study completion, an average of 6 month
Patient Specific Functional Scale	In the patient-specific activity scale, depending on the current pathology, the physiotherapist asks the patient three or five activities that he or she finds difficult to do. The patient is asked to score the activity between 0-10 points. The total score is determined by averaging the activity scores, with higher scores indicating better function.	through study completion, an average of 6 month

Collaborators and Investigators

• Sponsor: Ankara Yildirim Beyazıt University

Study record dates

Study Major Dates

• Study Start (Actual): June 1, 2022
• Primary Completion (Actual): October 25, 2022
• Study Completion (Actual): November 1, 2022

Study Registration Dates

• First Submitted: December 15, 2023
• First Submitted That Met QC Criteria: December 29, 2023
• First Posted (Estimated): January 1, 2024

Study Record Updates

• Last Update Posted (Estimated): January 1, 2024
• Last Update Submitted That Met QC Criteria: December 29, 2023
• Last Verified: December 1, 2023

More Information

Terms related to this study

• Other Study ID Numbers: 2022-962

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No